继发性骨质疏松症治疗

被引:17
作者
姜艳
孔晶
邢小平
机构
[1] 北京协和医院内分泌科
关键词
继发性骨质疏松; 糖皮质激素; 甲状腺激素; 原发性甲状旁腺功能亢进; 风湿性疾病;
D O I
暂无
中图分类号
R580 [];
学科分类号
摘要
<正>继发性骨质疏松症是指由于某些疾病、药物或其他原因造成骨量降低,骨骼的微结构发生改变,易发生脆性骨折的疾病[1]。常见的继发性原因见表1[2,3],诊断原发性骨质疏松症必须先排除继发性骨质疏松的
引用
收藏
页码:41 / 46
页数:6
相关论文
共 15 条
[1]
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial [J].
Reid, David M. ;
Devogelaer, Jean-Pierre ;
Saag, Kenneth ;
Roux, Christian ;
Lau, Chak-Sing ;
Reginster, Jean-Yves ;
Papanastasiou, Philemon ;
Ferreira, Alberto ;
Hartl, Florian ;
Fashola, Taiwo ;
Mesenbrink, Peter ;
Sambrook, Philip N. .
LANCET, 2009, 373 (9671) :1253-1263
[2]
Hyperparathyroidism [J].
Fraser, William D. .
LANCET, 2009, 374 (9684) :145-158
[3]
Glucocorticoid-induced osteoporosis: pathophysiology and therapy [J].
Canalis, E. ;
Mazziotti, G. ;
Giustina, A. ;
Bilezikian, J. P. .
OSTEOPOROSIS INTERNATIONAL, 2007, 18 (10) :1319-1328
[4]
The management of secondary osteoporosis [J].
Kelman, A ;
Lane, NE .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (06) :1021-1037
[5]
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer [J].
Howell, A ;
Cuzick, J ;
Baum, M ;
Buzdar, A ;
Dowsett, M ;
Forbes, JF ;
Hoctin-Boes, G ;
Houghton, I ;
Locker, GY ;
Tobias, JS .
LANCET, 2005, 365 (9453) :60-62
[6]
Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism [J].
Peacock, M ;
Bilezikian, JP ;
Klassen, PS ;
Guo, MD ;
Turner, SA ;
Shoback, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) :135-141
[7]
Transdermal estradiol improves bone density when used as single agent therapy for prostate cancer [J].
Ockrim, JL ;
Lalani, EN ;
Banks, LM ;
Svensson, WE ;
Blomley, MJ ;
Patel, S ;
Laniado, ME ;
Carter, SS ;
Abel, PD .
JOURNAL OF UROLOGY, 2004, 172 (06) :2203-2207
[8]
Secondary osteoporosis [J].
Stein, E ;
Shane, E .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2003, 32 (01) :115-+
[9]
Thyroid Hormones: Beneficial or Deleterious for Bone?.[J].P. Lakatos.Calcified Tissue International.2003, 3
[10]
Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced osteoporosis [J].
Rehman, Q ;
Lang, TF ;
Arnaud, CD ;
Modin, GW ;
Lane, NE .
OSTEOPOROSIS INTERNATIONAL, 2003, 14 (01) :77-81